Article
SCA44- and SCAR13-associated <i>GRM1</i> mutations affect metabotropic glutamate receptor 1 function through distinct mechanisms
2023-07-05
Abstract excerpt
Metabotropic glutamate receptor 1 (mGlu 1 ) is a promising therapeutic target for neurodegenerative CNS disorders including spinocerebellar ataxias (SCAs). Clinical reports have identified naturally-occurring mGlu 1 mutations in rare SCA subtypes and clinical symptoms of mGlu 1 mutations have been described. However, how mutations alter mGlu 1 function remains unknown. We explored SCA-associated mutation effec...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f63f9704-7bfe-55d8-9064-0504f444a175
- DOI
- 10.1101/2023.07.05.545810
